Skip to main content

releases

Major U.S. trial closes showing no benefit for hydroxychloroquine in COVID-19

Jun. 21, 2020—The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm. 

Read more


TERAVOLT registry tracks outcomes of treatments among people with thoracic cancers sickened by COVID-19

Jun. 12, 2020—New data from TERAVOLT, a global consortium that tracks outcomes of people with thoracic cancers affected by COVID-19, offers clues as to why they experienced a high death rate of 33% when the coronavirus swept across Europe.

Read more


Vanderbilt, AstraZeneca collaborate on new COVID-19 antibody research

Jun. 9, 2020—After evaluating the ability of more than 1,500 monoclonal antibodies to bind and neutralize the COVID-19 virus, SARS-CoV-2, in the laboratory, AstraZeneca signed an exclusive license to six candidate antibodies in Vanderbilt’s portfolio.

Read more


Fleming reflects on a life of love, purpose after terminal cancer diagnosis

Jun. 4, 2020—A month before his 49th birthday, Geoffrey Fleming, MD, had a biopsy of his liver to diagnose an unidentified metastatic disease that he already knew was “something bad.”

Read more


Core principles guiding the COVID-19 response and beyond

May. 15, 2020—During a first-ever virtual leadership assembly necessitated through social distancing, Vanderbilt University Medical Center leaders answered questions about the Medical Center’s response to COVID-19 so far and what the future could hold.

Read more


VUMC’s Capra, Bastarache set for Jan. 30 Cutting-Edge Discovery Lecture

Jan. 22, 2020—The intersection of genetics and electronic health records will be discussed by two Vanderbilt University researchers during a Cutting-Edge Discovery Lecture on Thursday, Jan. 30. The lecture will begin at 4 p.m. in 208 Light Hall.

Read more


Tennessee Receives Grant from Federal Government to Address Opioid Crisis

Dec. 20, 2019—The Division of TennCare will partner with VUMC as part of the MOM program focusing on 26 rural and urban counties to improve the outcomes for women with opioid use disorder and their infants.

Read more


AI’s Future Potential Hinges on Consensus: NAM Report

Dec. 18, 2019—The current explosion of investment and development in health care AI is happening without an underpinning of consensus of responsible, transparent deployment, which potentially constrains its potential.

Read more


Sleep experts: daylight saving time has long-term brain effects

Nov. 4, 2019—Sleep experts published a JAMA Neurology commentary in which they recap large epidemiological studies to advocate for ending the practice.

Read more


Langevin to headline inaugural Osher lecture series

Oct. 18, 2019—Dr. Helene Langevin is the inaugural speaker of a new lecture series on Oct. 29, 2019, hosted by the Osher Center for Integrative Medicine at Vanderbilt.

Read more


The Science of Mindfulness — What Do We Really Know and Where Do We Go?

Oct. 2, 2019—Rapid advancements in technology allows us to more accurately understand how mindfulness impacts, or changes, the brain, which is contributing to what we know. David Vago, PhD, explains.

Read more


VU basketball great Foster relates crucial role of mentors

Feb. 28, 2019—Vanderbilt Behavioral Health (VBH) recently hosted Shan Foster — former basketball player for the Vanderbilt Commodores and Dallas Mavericks — for a Black History Month presentation on achievements that stem from strong mentors.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more